Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Catalyst Bio (NQ: CBIO)
10.59 USD  +0.32 (+3.12%)
Official Closing Price  /  Updated: 5:02 PM EDT, Aug 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 88,500
Open 10.27
Bid (Size) 10.02 (1)
Ask (Size) 10.70 (1)
Prev. Close 10.27
Today's Range 10.27 - 10.62
52wk Range 3.110 - 36.50
Shares Outstanding 11,935,169
Dividend Yield N/A
Performance
YTD
-26.30%
-26.30%
1 Month
-1.03%
-1.03%
3 Month
-57.30%
-57.30%
6 Month
-64.10%
-64.10%
1 Year
+214.24%
+214.24%
Top News
More News
Report: Developing Opportunities within The Providence Service, NVE, StoneMor Partners, Midland States, Destination XL Group, and Catalyst Biosciences — Future Expectations, Projections Moving into 20
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Providence Service... Read More
from GlobeNewswire News Releases
Catalyst Biosciences Announces Updated Positive Interim Data at the 2018 Hemophilia Drug Development Summit
Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced updated positive interim... Read More
from GlobeNewswire News Releases
More News
Read More
Catalyst Biosciences Announces Oral Presentation at the 2018 Hemophilia Drug Development Summit
from GlobeNewswire News Releases
Catalyst Biosciences Reports Second Quarter Operating & Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
from GlobeNewswire News Releases
Free Technical Briefing on Biotechnology Stocks -- Catalyst Biosciences, PolarityTE, CEL-SCI, and Daré Bioscience
from PR Newswire
Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
from GlobeNewswire News Releases
Catalyst Biosciences Announces Appointment of Grant Blouse, Ph.D., as Vice President of Translational Research
from GlobeNewswire News Releases
Catalyst Biosciences Joins the Russell 2000® Index
from GlobeNewswire News Releases
Analysts Anticipate PZI Will Reach $23
category ETFs
from ETF Channel
Notable Wednesday Option Activity: TIVO, CBIO, AAOI
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.